✦ LIBER ✦

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial

✍ Scribed by David Fogelman; Mehrdad Jafari; Gauri R. Varadhachary; Henry Xiong; Susie Bullock; Harold Ozer; E. Lin; Jeffrey Morris; Patti Cunningham; Bronwyn Bennett; James L. Abbruzzese; Robert A. Wolff

Publisher: Springer
Year: 2011
Tongue: English
Weight: 216 KB
Volume: 68
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1601-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and oxaliplatin combination

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study

✍ Kyung Hee Lee; Min Kyoung Kim; Yeol Hong Kim; Baek Yeol Ryoo; Ho Yeong Lim; Hong 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 341 KB

A phase I study of imexon plus gemcitabi

A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

✍ Steven J. Cohen; Mark M. Zalupski; Manuel R. Modiano; Paul Conkling; Yehuda Z. P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 275 KB

Phase 2 trial of oxaliplatin plus capeci

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer

✍ Henry Q. Xiong; Gauri R. Varadhachary; Joan C. Blais; Kenneth R. Hess; James L. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

Non-pegylated liposomal doxorubicin comb

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

✍ S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB

Final results of a phase II study ofnab-

Final results of a phase II study ofnab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

✍ Christopher Lobo; Gilberto Lopes; Odalys Baez; Aurelio Castrellon; Annapoorna Fe 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 268 KB

Phase II trial of a 2-h infusion of gemc

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

✍ N. Xu; P. Shen; X. C. Zhang; L. F. Yu; H. Y. Bao; G. M. Shi; S. Huang; J. Chen; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 302 KB